Andreas Halvorsen: portfolio of Viking Global Investors
Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.
Source: 13F filing with the US Securities and Exchange Commission dated Aug 16, 2021. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q2 2021. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 32.9B USD
- Positions
- 87
- Share of the ten largest
- 36.8%
The ten largest positions Q2 2021
- Amazon 5.0%▲ +161.9%
- Bridgebio Pharma Inc 4.9%unchanged
- Fidelity National Information Services 4.0%▼ −4.1%
- Microsoft 3.8%▼ −45.3%
- GE Aerospace 3.8%▲ +51.3%
- Adaptive Biotechnologies Cor 3.7%unchanged
- T-Mobile US 3.3%▼ −26.7%
- Palo Alto Networks 3.0%▲ +5.3%
- Coupa Software Inc 2.9%▲ +100.6%
- Fortive 2.5%▲ +5.3%
Show all positions of this quarter
Choose a quarter (54 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
All positions Q2 2021
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| AMZN Amazon | 5.0% | 474,217 | 1.6B USD | +161.9% increased | Q2 2015 25 quarters |
| Bridgebio Pharma Inc | 4.9% | 26,620,991 | 1.6B USD | unchanged | Q2 2019 9 quarters |
| FIS Fidelity National Information Services | 4.0% | 9,200,315 | 1.3B USD | −4.1% reduced | Q4 2019 7 quarters |
| MSFT Microsoft | 3.8% | 4,655,350 | 1.3B USD | −45.3% reduced | Q2 2016 21 quarters |
| GE GE Aerospace | 3.8% | 91,790,079 | 1.2B USD | +51.3% increased | Q4 2020 3 quarters |
| Adaptive Biotechnologies Cor | 3.7% | 29,993,708 | 1.2B USD | unchanged | Q2 2019 9 quarters |
| TMUS T-Mobile US | 3.3% | 7,542,189 | 1.1B USD | −26.7% reduced | Q1 2020 6 quarters |
| PANW Palo Alto Networks | 3.0% | 2,640,393 | 979.7M USD | +5.3% increased | Q4 2020 3 quarters |
| Coupa Software Inc | 2.9% | 3,599,829 | 943.6M USD | +100.6% increased | Q1 2021 2 quarters |
| FTV Fortive | 2.5% | 11,778,211 | 821.4M USD | +5.3% increased | Q3 2019 8 quarters |
| CNC Centene Corporation | 2.5% | 11,199,941 | 816.8M USD | +2.0% increased | Q2 2018 13 quarters |
| NOW ServiceNow | 2.5% | 1,482,387 | 814.6M USD | +64.2% increased | Q4 2020 3 quarters |
| CB Chubb Limited | 2.4% | 4,920,334 | 782.0M USD | +17.7% increased | Q1 2020 6 quarters |
| BMY Bristol Myers Squibb | 2.3% | 11,317,752 | 756.3M USD | +117.8% increased | Q3 2020 4 quarters |
| Figs Inc | 2.3% | 14,942,689 | 748.6M USD | new | Q2 2021 1 quarter |
| Fleetcor Technologies Inc | 2.2% | 2,872,814 | 735.6M USD | +9.1% increased | Q3 2020 4 quarters |
| UNH UnitedHealth Group | 2.2% | 1,798,650 | 720.3M USD | −41.6% reduced | Q4 2020 3 quarters |
| META Meta Platforms | 2.1% | 2,030,659 | 706.1M USD | −13.5% reduced | Q4 2020 3 quarters |
| Api Group Corp | 2.1% | 33,333,333 | 696.3M USD | unchanged | Q2 2020 5 quarters |
| AON Aon plc | 2.1% | 2,903,054 | 693.1M USD | +34.7% increased | Q3 2018 12 quarters |
| JD JD.com (ADR) | 2.0% | 8,241,079 | 657.7M USD | new | Q2 2021 1 quarter |
| BSX Boston Scientific | 1.7% | 13,315,816 | 569.4M USD | −25.6% reduced | Q3 2018 12 quarters |
| Guardant Health Inc | 1.6% | 4,256,363 | 528.6M USD | +45.9% increased | Q3 2019 8 quarters |
| V Visa Inc. | 1.6% | 2,219,163 | 518.9M USD | −45.0% reduced | Q3 2016 20 quarters |
| TMO Thermo Fisher Scientific | 1.5% | 1,011,401 | 510.2M USD | +17.3% increased | Q2 2020 5 quarters |
| ZBH Zimmer Biomet | 1.4% | 2,954,171 | 475.1M USD | −22.7% reduced | Q3 2020 4 quarters |
| NFLX Netflix | 1.4% | 878,544 | 464.1M USD | +17.1% increased | Q1 2021 2 quarters |
| DE Deere & Company | 1.4% | 1,287,395 | 454.1M USD | +84.9% increased | Q1 2021 2 quarters |
| PODD Insulet Corporation | 1.3% | 1,595,288 | 437.9M USD | +54.0% increased | Q3 2020 4 quarters |
| Avantor Inc | 1.3% | 11,732,062 | 416.6M USD | −24.3% reduced | Q2 2019 9 quarters |
| AMP Ameriprise Financial | 1.2% | 1,539,788 | 383.2M USD | +81.6% increased | Q1 2021 2 quarters |
| Match Group Inc New | 1.2% | 2,356,406 | 380.0M USD | +15.8% increased | Q4 2020 3 quarters |
| Laboratory Corp Amer HLDGS | 1.2% | 1,373,414 | 378.9M USD | +27.0% increased | Q3 2020 4 quarters |
| AIZ Assurant | 1.1% | 2,411,046 | 376.6M USD | −13.1% reduced | Q2 2019 9 quarters |
| Icici Bank Limited | 1.1% | 21,070,884 | 360.3M USD | new | Q2 2021 1 quarter |
| IR Ingersoll Rand | 1.0% | 6,417,254 | 313.2M USD | +19.5% increased | Q1 2020 6 quarters |
| BAC Bank of America | 0.9% | 7,174,216 | 295.8M USD | −77.1% reduced | Q1 2021 2 quarters |
| MRSH Marsh McLennan | 0.9% | 2,057,461 | 289.4M USD | −1.2% reduced | Q4 2020 3 quarters |
| Lithia Mtrs Inc | 0.8% | 807,493 | 277.5M USD | +148.2% increased | Q1 2021 2 quarters |
| Zai Lab Ltd | 0.8% | 1,539,257 | 272.4M USD | +107.2% increased | Q1 2021 2 quarters |
| HUM Humana | 0.8% | 588,285 | 260.4M USD | new | Q2 2021 1 quarter |
| RUN Sunrun | 0.8% | 4,464,114 | 249.0M USD | +1.5% increased | Q1 2021 2 quarters |
| ALGN Align Technology | 0.7% | 404,087 | 246.9M USD | −25.8% reduced | Q2 2020 5 quarters |
| Molina Healthcare Inc | 0.7% | 973,356 | 246.3M USD | −32.1% reduced | Q3 2019 8 quarters |
| Brookfield Asset Mgmt Inc | 0.6% | 4,130,609 | 210.6M USD | new | Q2 2021 1 quarter |
| PH Parker Hannifin | 0.6% | 666,117 | 204.6M USD | −18.6% reduced | Q2 2020 5 quarters |
| BKNG Booking Holdings | 0.6% | 90,093 | 197.1M USD | new | Q2 2021 1 quarter |
| XYZ Block, Inc. | 0.5% | 655,437 | 159.8M USD | new | Q2 2021 1 quarter |
| Intellia Therapeutics Inc | 0.5% | 975,092 | 157.9M USD | new | Q2 2021 1 quarter |
| Tenet Healthcare Corp | 0.5% | 2,279,182 | 152.7M USD | +56.0% increased | Q1 2021 2 quarters |
| SHOP Shopify | 0.5% | 104,441 | 152.6M USD | −2.0% reduced | Q1 2021 2 quarters |
| Inhibrx Inc | 0.4% | 5,305,866 | 146.0M USD | unchanged | Q3 2020 4 quarters |
| TEAM Atlassian | 0.4% | 523,941 | 134.6M USD | new | Q2 2021 1 quarter |
| GOOGL Alphabet Inc. (Class A) | 0.4% | 54,637 | 133.4M USD | −88.0% reduced | Q3 2020 4 quarters |
| Royalty Pharma PLC | 0.4% | 3,238,654 | 132.8M USD | +57.1% increased | Q2 2020 5 quarters |
| SNOW Snowflake | 0.4% | 545,741 | 132.0M USD | −13.0% reduced | Q3 2020 4 quarters |
| CRL Charles River Laboratories | 0.4% | 351,868 | 130.2M USD | −21.6% reduced | Q1 2021 2 quarters |
| Acadia Healthcare Company In | 0.4% | 2,060,125 | 129.3M USD | +24.7% increased | Q4 2020 3 quarters |
| Zentalis Pharmaceuticals Inc | 0.4% | 2,399,284 | 127.6M USD | unchanged | Q2 2020 5 quarters |
| Zoominfo Technologies Inc | 0.4% | 2,381,274 | 124.2M USD | new | Q2 2021 1 quarter |
| Catalent Inc | 0.4% | 1,118,465 | 120.9M USD | +48.3% increased | Q1 2018 14 quarters |
| Walgreens Boots Alliance Inc | 0.3% | 2,168,879 | 114.1M USD | +26.3% increased | Q1 2021 2 quarters |
| Horizon Therapeutics Pub L | 0.3% | 1,170,211 | 109.6M USD | −44.7% reduced | Q1 2020 6 quarters |
| 4D Molecular Therapeutics In | 0.3% | 3,937,914 | 94.8M USD | unchanged | Q4 2020 3 quarters |
| Karuna Therapeutics Inc | 0.3% | 822,465 | 93.8M USD | +36.8% increased | Q3 2020 4 quarters |
| Adapthealth Corp | 0.3% | 3,096,428 | 84.9M USD | new | Q2 2021 1 quarter |
| DASH DoorDash | 0.3% | 463,778 | 82.7M USD | −24.0% reduced | Q4 2020 3 quarters |
| CHTR Charter Communications | 0.2% | 111,727 | 80.6M USD | new | Q2 2021 1 quarter |
| IFF International Flavors & Fragrances | 0.2% | 508,434 | 76.0M USD | new | Q2 2021 1 quarter |
| Pvh Corporation | 0.2% | 639,474 | 68.8M USD | −31.5% reduced | Q2 2020 5 quarters |
| Peloton Interactive Inc | 0.2% | 524,792 | 65.1M USD | new | Q2 2021 1 quarter |
| Pmv Pharmaceuticals Inc | 0.2% | 1,790,284 | 61.2M USD | −14.2% reduced | Q3 2020 4 quarters |
| Edgewise Therapeutics Inc | 0.2% | 2,727,249 | 58.2M USD | −18.6% reduced | Q1 2021 2 quarters |
| Canadian Natl Ry Co | 0.2% | 537,655 | 56.7M USD | new | Q2 2021 1 quarter |
| Talaris Therapeutics Inc | 0.1% | 3,289,617 | 48.3M USD | new | Q2 2021 1 quarter |
| Pacific Biosciences Calif In | 0.1% | 1,273,659 | 44.5M USD | +334.2% increased | Q3 2020 4 quarters |
| Pharvaris N V | 0.1% | 2,391,517 | 43.5M USD | −1.2% reduced | Q1 2021 2 quarters |
| Kinnate Biopharma Inc | 0.1% | 1,820,462 | 42.4M USD | −2.8% reduced | Q4 2020 3 quarters |
| Mudrick Capital Acqu Corp II | 0.1% | 3,048,405 | 38.0M USD | new | Q2 2021 1 quarter |
| Orion Acquisition Corp | 0.1% | 3,597,342 | 35.7M USD | −1.1% reduced | Q1 2021 2 quarters |
| BILI Bilibili | < 0.1% | 266,483 | 32.5M USD | −42.5% reduced | Q4 2020 3 quarters |
| Day One Biopharmaceuticals I | < 0.1% | 1,341,396 | 30.5M USD | new | Q2 2021 1 quarter |
| Acceleron Pharma Inc | < 0.1% | 196,136 | 24.6M USD | new | Q2 2021 1 quarter |
| Kanzhun Limited | < 0.1% | 545,726 | 21.6M USD | new | Q2 2021 1 quarter |
| Gracell Biotechnologies Inc | < 0.1% | 1,330,328 | 17.3M USD | −1.1% reduced | Q1 2021 2 quarters |
| Smart Sh Global Ltd | < 0.1% | 470,000 | 2.9M USD | new | Q2 2021 1 quarter |
| Brookfield Asset Mgmt Reins | < 0.1% | 24,077 | 1.3M USD | new | Q2 2021 1 quarter |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Plus 1 position in convertible bonds and bonds worth 57.9M USD as reported – not included in the weights.
Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.
- Coupa Software Inc principal 50.0M USD 57.9M USD
Breakdown by sector
- Health Care 15.0%
- Financials 14.6%
- Industrials 10.0%
- Technology 9.7%
- Communication Services 7.5%
- Consumer Discretionary 5.8%
- Materials 0.2%
- not in our coverage 37.3%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors